Member Log-in

I forgot my password

Not a Member? Register

Focus Area: <span>Maintaining political will and commitment during transition</span>

Results 1 -10 of 16

LNCT Materials to Help you Make the Case for Investing in Immunization

Why We Need to Make a Case for Investment

Maintaining a high performing immunization program requires sustained commitment and funding over time.  Ongoing communication and advocacy are needed to maintain investments and to stimulate additional investments to achieve health goals. Advocating for resources for immunization at national and sub-national levels requires demonstrating the health and economic impact of proposed investments to convince decision makers to allocate funding for immunization.

… Continued
Read

Re-evaluating the Potential Impact and Cost-effectiveness of Rotavirus Vaccination in 73 Gavi Countries: A Modelling Study

 | Frédéric Debellut, Andrew Clark, Clint Pecenka, Jacqueline Tate, Ranju Baral, Colin Sanderson, et al.
Background Previous studies have found rotavirus vaccination to be highly cost-effective in low-income countries. However, updated evidence is now available for several inputs (ie, rotavirus disease mortality rates, rotavirus age distributions, vaccine timeliness, and vaccine efficacy by duration of follow-up), new rotavirus vaccines have entered the market, vaccine prices have decreased, and cost-effectiveness thresholds have been re-examined. We aimed to provide updated cost-effectiveness estimates to inform national decisions about the new introduction and current use of rotavirus vaccines in Gavi countries. … Continued
Read

Rotavirus Vaccination is Cost Effective and Saves Lives, New Analysis Finds

In an analysis published in the December issue of The Lancet Global Health, investigators from PATH, the London School of Hygiene & Tropical Medicine, and the US Centers for Disease Control and Prevention, analyzed the potential costs of rotavirus vaccination for 10 successive birth cohorts (from 2018 through 2027) in 73 countries eligible for Gavi support, compared … Continued

Georgia’s Introduction of the Hexavalent Vaccine: Lessons on Successful Procurement and Advocacy

This blog is also available in Russian. 

Authors: Eka Paatashvili and Vladimer Getia

As countries transition from Gavi support, sustaining access to affordable and high-quality vaccines is one of many challenges they face. Fully self-financing countries need to maintain their immunization programs while also committing increased funds for new vaccine introductions.

… Continued
Read

Measles Outbreaks in an Interconnected World

Orin Levine, Director of Vaccine Delivery at the Bill and Melinda Gates Foundation, shared why he believes in vaccination in an early interview with The Optimist. He recently wrote a new piece for CBS on how resurgent measles outbreaks are underscoring the importance of vaccines. Please find an excerpt below, which originally appeared in February’s … Continued

UNICEF Immunization Financing in MENA Middle-Income Countries

 | UNICEF MENARO, Miloud Kaddar, Helen Saxenian, MK International Consulting, Nahad Sadr-Azodi, and Kamel Senouci

Most Middle East and North Africa (MENA) countries have high immunization coverage rates. But immunization coverage has dropped considerably in some (including Iraq, the Syrian Arab Republic and Yemen), due to the conflicts, instability and the prevailing geopolitical situation in the region. Approximately 1.3 million surviving infants in MENA missed their third dose of DTP vaccine in 2016.

… Continued
Read

WHO Immunization Advocacy Resource Library

 | World Health Organization

World Health Organization’s (WHO) Immunization advocacy library contains useful resources, information, and factsheets related to messaging on immunization and data on vaccination that can help immunization program managers and other stakeholders advocate for prioritization of immunization in political agendas and public health budgets.

… Continued
Read

Global Vaccine Action Plan (GVAP) 2011-2020

 | World Health Organization

The Global Vaccine Action Plan (GVAP) is a framework approved by the World Health Assembly in May 2012 to achieve the Decade of Vaccines vision by delivering universal access to immunization. The mission outlined in the GVAP is straightforward: improve health by extending by 2020 and beyond the full benefits of immunization to all people, regardless of where they are born,

… Continued
Read

Value of Immunization Compendium of Evidence (VoICE) Tool

 | International Vaccine Access Center

VoICE is a browsable, queryable online database intended to capture the many ways in which immunization can be valued, and the evidence supporting this more comprehensive view of the value of vaccination. The information contained in the compendium has been drawn from peer-reviewed literature, expert commentaries and other high quality sources and synthesized with policy-focused global health advocacy organizations in mind.

… Continued
Read

Choose a Language